7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Eloxx Pharmaceuticals, Inc
(NASDAQ:ELOX) 

ELOX stock logo

Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribonucleic acid modulating drug candidates for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical t...

Founded: 1999
Full Time Employees: 29
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends
Eloxx Pharmaceuticals Op Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -16.67-14.29-11.91-9.53-7.14-4.76-2.380
Eloxx Pharmaceuticals Free Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -16.71-14.32-11.94-9.55-7.16-4.77-2.390
Eloxx Pharmaceuticals Cash Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 01.623.244.866.488.19.7111.33
Eloxx Pharmaceuticals (GAAP) P/E ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -19.07-16.35-13.62-10.9-8.17-5.45-2.720
Eloxx Pharmaceuticals P/B ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -25.7-19.61-13.53-7.44-1.364.7310.8216.9
No extra charts and metrics for this ticker.